Indian generic drug firm Ranbaxy announces joint venture

07 February, 2006

India-based generic drug company Ranbaxy Laboratories, the maker of erecrtile dysfunction (ED) generic pill Caverta has announced on Monday that it had entered a joint venture with the South Africa-based firm Community Investment Holdings to sell Ranbaxy's anti-retroviral drugs in Africa.

Ranbaxy South Africa CEO Desmond Brothers said the venture will allow the company to sell its drugs at a low cost. Ranbaxy will hold 70% of the venture, named Sonke Pharmaceuticals, which will sell products under the trademark "Sonke”. Products will be available through governments, retail pharmacists, HIV/AIDS disease management companies, non-governmental organizations and independent community treatment organizations in South Africa, Botswana and Namibia.


To read more, Visit:
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=35246